RxDoctor Payments Data

Nicole Redondo

Child & Adolescent Psychiatry · Miami, FLNPI 1982198909

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 28.0% of the total.

$4,262in general payments, 2019–2025

Across 121 payments — averaging $35.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$559
  • Indivior Inc.$523
  • Corium, LLC$388
  • Idorsia Pharmaceuticals US Inc$268
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$261
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$4,262100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,262 in reported general payments places this provider in the 85th percentile of 206 child & adolescent psychiatry providers in Florida.

See all child & adolescent psychiatry providers in Florida

Other child & adolescent psychiatry in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →